News and Insights

New Commercial Models

Design Principles for Value-Based Solutions

Hospitals and healthcare delivery systems are facing significant pressure to improve quality, reduce costs, and increase revenues.  As a result, they are putting pressure on medical device manufacturers for lower prices and better outcomes.  In addition, they’re introducing other restrictions – like reducing the number of suppliers, limiting physician access,…

What Population Health Means for Manufacturers

It’s no secret that the healthcare industry is under growing pressure to reduce the cost of care while improving quality. Linkage of payment for healthcare to the cost and quality delivered is the idea behind value-based payment frameworks, and is the driving force behind today’s rapidly changing healthcare landscape. Such…

Adapting the Commercial Process to the Evolving Healthcare Delivery Landscape

eyeforpharma

In July 2016, CMS’ announced that it plans to initiate a mandatory bundled-payment program in cardiology that parallels its current orthopedic bundled pricing program. This is another indication of CMS’ commitment to alternative payment models that make delivery organizations financially accountable for the cost and quality of care they provide.…

Population Health and Its Implications for Manufacturers

eyeforpharma

It’s no secret that the global healthcare industry is increasingly challenged to reduce costs while still delivering innovative, high-quality care. This transition toward a value-based framework for healthcare delivery and payment is the driving force behind today’s rapidly changing healthcare landscape. In past columns, I’ve discussed the growing importance of…

5 Tips On How To Compete in Bundled Care Environment

MD&DI

On the morning of April 1, hospital and medical device company executives woke up to yet another new chapter in bundled pricing — CMS’ Comprehensive Care for Joint Replacement (CJR) initiative. Unlike the Bundled Payments for Care Improvement (BPCI) programs that preceded it, there is no opt-out clause for the…